Literature DB >> 25559248

High-level expression and one-step purification of a soluble recombinant human interleukin-37b in Escherichia coli.

Jiajie Gu1, Xueming Gao1, Xiuhe Pan1, Xiao Peng1, Yan Li2, Mingcai Li3.   

Abstract

Interleukin (IL)-37 is a novel member of the IL-1 cytokine family. However, as a result of lacking efficient method to generate relatively large quantity of IL-37, little is known of its functions in man. In the present study, the recombinant human IL-37b containing a C-hexahistidine tag was expressed in Escherichia coli (E. coli). The expression level of IL-37b in E. coli was very high after induction with IPTG. Furthermore, IL-37b protein was largely found in the soluble fraction. The expressed protein was readily purified by one-step immobilized metal-ion affinity chromatography using Ni(2+)-nitrilotriacetic acid agarose. The purified IL-37b appeared as a single band on SDS-PAGE and the purity was more than 97%. The yield was 90mg IL-37b from 1l of bacterial culture. Western blotting and N-terminal sequencing confirmed the identity of the purified protein. The purified IL-37b inhibited significantly the release of tumor necrosis factor-α and IL-1β in lipopolysaccharide-activated THP-1 cells. Thus, this method provides an efficient way to obtain an active IL-37 with high yield and high purity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  His-tag fusion protein; Interleukin-37; Recombinant; Soluble expression

Mesh:

Substances:

Year:  2015        PMID: 25559248     DOI: 10.1016/j.pep.2014.12.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

Review 1.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 2.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

Review 3.  The potential of interleukin-37 as an effective therapeutic agent in asthma.

Authors:  Lina Zhang; Jie Zhang; Peng Gao
Journal:  Respir Res       Date:  2017-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.